Living with Parkinson’s disease and connected to the duodopa pump: A qualitative study

Yolanda María  Chacón Gámez; Nikola Biller-Andorno

doi:10.4081/qrmh.2020.9427

Authors

Yolanda María Chacón Gámez
yolanda.chacon@ibme.uzh.ch
Institute of Medical Bioethics and History of Medicine, University of Zurich, Switzerland.
Nikola Biller-Andorno Institute of Medical Bioethics and History of Medicine, University of Zurich, Switzerland.

Parkinson’s Disease (PD) is a complex and heterogeneous disease that has a major impact on the lives of patients and their family caregivers. The duodopa pump is one of the treatments options for advanced PD. The experience of patients with this treatment is largely unexplored, however. This study is based on the experiences of patients with PD as well as their family caregivers using the pump. We take a multimodal approach that includes narrative semi-structured interviews and drawings. This methodology helps participants, particularly those with difficulty articulating themselves, express their experience with the disease and their perception of the treatment. We believe that the use of drawings complementing semi-structured interviews offers additional insights into the participants’ perception of PD and the pump. In this article we focus on the following topics: the participants’ perception of PD and the pump, the reasons for choosing the pump over alternatives, and the advantages and disadvantages of this treatment for patients and family caregivers. Our findings show that the participants consider PD as a complex and unpredictable disease that changed their lives and affect everyone differently, while the pump makes the disease less changeable and more manageable.

Hayes MT. Parkinson’s Disease and Parkinsonism. Am J Med 2019;132:802–7. DOI: https://doi.org/10.1016/j.amjmed.2019.03.001

Kulisevsky J, Oliveira L, Fox SH. Update in therapeutic strategies for Parkinsonʼs disease: Curr Opin Neurol 2018;31:439–47. DOI: https://doi.org/10.1097/WCO.0000000000000579

Soundy A, Stubbs B, Roskell C. The Experience of Parkinson’s Disease: A Systematic Review and Meta-Ethnography. Sci World J 2014;2014:613592. DOI: https://doi.org/10.1155/2014/613592

Calne SM. The Psychosocial Impact of Late-Stage Parkinsonʼs Disease. J Neurosci Nurs 2003;35:306–13. DOI: https://doi.org/10.1097/01376517-200312000-00004

Ray Chaudhuri K, Qamar MA, Rajah T, Loehrer P, Sauerbier A, Odin P, et al. Non-oral dopaminergic therapies for Parkinson’s disease: current treatments and the future. Npj Park Dis 2016;2:16023. DOI: https://doi.org/10.1038/npjparkd.2016.23

Odin P, Wolters E, Antonini A. Continuous dopaminergic stimulation achieved by duodenal levodopa infusion. Neurol Sci 2008;29:387–8. DOI: https://doi.org/10.1007/s10072-008-1054-7

Marshall T, Pugh A, Fairchild A, Hass S. Patient Preferences for Device-Aided Treatments Indicated for Advanced Parkinson Disease. Value Health 2017;20:1383–93. DOI: https://doi.org/10.1016/j.jval.2017.06.001

Hariz G-M, Hamberg K. Perceptions of Living With a Device-Based Treatment: An Account of Patients Treated With Deep Brain Stimulation for Parkinson’s Disease: Parkinson Patients’ Views of Their DBS Device. Neuromodulation Technol Neural Interface 2014;17:272–8. DOI: https://doi.org/10.1111/ner.12073

Ziebland S, McPherson A. Making sense of qualitative data analysis: an introduction with illustrations from DIPEx (personal experiences of health and illness). Med Educ 2006;40:405–14. DOI: https://doi.org/10.1111/j.1365-2929.2006.02467.x

Ziebland S, Herxheimer A. How patients’ experiences contribute to decision making: illustrations from DIPEx (personal experiences of health and illness). J Nurs Manag 2008;16:433–9. DOI: https://doi.org/10.1111/j.1365-2834.2008.00863.x

Jewitt C, editor. The Routledge handbook of multimodal analysis. Second edition, first published in paperback. London New York: Routledge, Taylor & Francis Group; 2017: p. 527.

Adami E. Multimodality. 2015. Accessed 2021 Feb 8. Available from: http://rgdoi.net/10.13140/RG.2.1.4818.0565

Broadbent E, Petrie KJ, Ellis CJ, Ying J, Gamble G. A picture of health—myocardial infarction patients’ drawings of their hearts and subsequent disability. J Psychosom Res 2004;57:583–7. DOI: https://doi.org/10.1016/j.jpsychores.2004.03.014

Thorpe C, Arbeau KJ, Budlong B. ‘I drew the parts of my body in proportion to how much PCOS ruined them’: Experiences of polycystic ovary syndrome through drawings. Health Psychol Open 2019;6:2055102919896238. DOI: https://doi.org/10.1177/2055102919896238

Broadbent E, Niederhoffer K, Hague T, et al. Headache sufferers’ drawings reflect distress, disability and illness perceptions. J Psychosom Res 2009;66:465–70. DOI: https://doi.org/10.1016/j.jpsychores.2008.09.006

Brailas, A. Using Drawings in Qualitative Interviews: An Introduction to the Practice. Qual Rep 2020;25:4447–60.

Morgan M, McInerney F, Rumbold J, Liamputtong P. Drawing the experience of chronic vaginal thrush and complementary and alternative medicine. Int J Soc Res Methodol 2009;12:127–46. DOI: https://doi.org/10.1080/13645570902752316

Guillemin M. Understanding illness: using drawings as a research method. Qual Health Res 2004;14:272–89. DOI: https://doi.org/10.1177/1049732303260445

Strauss AL, Corbin JM. Basics of qualitative research: techniques and procedures for developing grounded theory. 2nd ed. Thousand Oaks: Sage Publications; 1998: p. 312.

Bryman A. Social research methods. Fifth Edition. Oxford ; New York: Oxford University Press; 2016: p. 747.

Greenland JC, Williams-Gray CH, Barker RA. The clinical heterogeneity of Parkinson’s disease and its therapeutic implications. Eur J Neurosci 2019;49:328–38. DOI: https://doi.org/10.1111/ejn.14094

Borovac JA. Side effects of a dopamine agonist therapy for Parkinson’s disease: a mini-review of clinical pharmacology. Yale J Biol Med 2016;89:37–47.

Padovani C, Lopes MC de L, Higahashi IH, Pelloso SM, Paiano M, Christophoro R. Being caregiver of people with Parkinson’s Disease: experienced situations. Rev Bras Enferm 2018;71:2628–34. DOI: https://doi.org/10.1590/0034-7167-2017-0008

Volkmann J, Albanese A, Antonini A, Chaudhuri KR, Clarke CE, de Bie RMA, et al. Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review. J Neurol 2013;260:2701–14. DOI: https://doi.org/10.1007/s00415-012-6798-6

Merritt RK, Hotham S, Graham L, Schrag A. The subjective experience of Parkinson’s disease: A qualitative study in 60 people with mild to moderate Parkinson’s in 11 European countries. Eur J Pers Centered Healthcare 2018;6:447. DOI: https://doi.org/10.5750/ejpch.v6i3.1536

Soleimani MA, Bastani F, Negarandeh R, Greysen R. Perceptions of people living with Parkinson’s disease: a qualitative study in Iran. Br J Community Nurs 2016;21:188–95. DOI: https://doi.org/10.12968/bjcn.2016.21.4.188

Plouvier AOA, Olde Hartman TC, van Litsenburg A, et al. Being in control of Parkinson’s disease: A qualitative study of community-dwelling patients’ coping with changes in care. Eur J Gen Pract 2018;24:138–45. DOI: https://doi.org/10.1080/13814788.2018.1447561

McLaughlin D, Hasson F, Kernohan WG, et al. Living and coping with Parkinson’s disease: perceptions of informal carers. Palliat Med 2011;25:177–82. DOI: https://doi.org/10.1177/0269216310385604

Chiong-Rivero H, Ryan GW, Flippen C, et al. Patients’ and caregivers’ experiences of the impact of Parkinson’s disease on health status. Patient Relat Outcome Meas 2011;2011:57–70. DOI: https://doi.org/10.2147/PROM.S15986

Rastgardani T, Armstrong MJ, Marras C, Gagliardi AR. Improving patient-centred care for persons with Parkinson’s: Qualitative interviews with care partners about their engagement in discussions of ‘off’ periods. Health Expect Int J Public Particip Health Care Health Policy 2019;22:555–64. DOI: https://doi.org/10.1111/hex.12884

van der Have M, Minderhoud IM, Kaptein AA, et al. Substantial impact of illness perceptions on quality of life in patients with Crohn’s disease. J Crohns Colitis 2013;7:e292–301. DOI: https://doi.org/10.1016/j.crohns.2012.11.002

Van Reenen E, Van Der Borg W, Visse M, et al. Fear, fight, familiarize: the experiences of people living with relapsing-remitting multiple sclerosis and taking oral medication. Int J Qual Stud Health Well-Being. 2019;14:1648946. DOI: https://doi.org/10.1080/17482631.2019.1648946

Jewitt C. Multimodal Methods for Researching Digital Technologies. In: The SAGE Handbook of Digital Technology Research [Internet]. London, United Kingdom: SAGE Publications Ltd; 2013. Accessed 2021 Jan 29. p. 250–65. Available from: http://methods.sagepub.com/book/the-sage-handbook-of-digital-technology-research/n18.xml DOI: https://doi.org/10.4135/9781446282229.n18

Bock Z. Multimodality, creativity and children’s meaning-making: drawings, writings, imaginings. Stellenbosch Pap Linguist PLUS [Internet]. 2016;49:1-21. DOI: https://doi.org/10.5842/49-0-669

Rollins JA. Tell me about it: drawing as a communication tool for children with cancer. J Pediatr Oncol Nurs Off J Assoc Pediatr Oncol Nurses 2005;22:203–21. DOI: https://doi.org/10.1177/1043454205277103

Cheung MMY, Saini B, Smith L. Using drawings to explore patients’ perceptions of their illness: a scoping review. J Multidiscip Healthcare 2016;9:631–46. DOI: https://doi.org/10.2147/JMDH.S120300

Scott A. Illness Meanings of AIDS Among Women With HIV: Merging Immunology and Life Experience. Qual Health Res 2009;19:454–65. DOI: https://doi.org/10.1177/1049732309332707

Besser SJ, Anderson JE, Weinman J. How do osteoporosis patients perceive their illness and treatment? Implications for clinical practice. Arch Osteoporos 2012;7:115–24. DOI: https://doi.org/10.1007/s11657-012-0089-9

Kirkham JA, Smith JA, Havsteen-Franklin D. Painting pain: An interpretative phenomenological analysis of representations of living with chronic pain. Health Psychol 2015;34:398–406. DOI: https://doi.org/10.1037/hea0000139

Guillemin MM, Westall C. Gaining insight into women’s knowing of postnatal depression using drawings. In: Knowing differently: arts-based and collaborative research method. First. Nova Science Publishers; p. 121-39.

Witek N, Stebbins GT, Goetz CG. What influences placebo and nocebo responses in Parkinson’s disease?: Placebo and Nocebo Response in PD. Mov Disord 2018;33:1204–12. DOI: https://doi.org/10.1002/mds.27416

Chacón Gámez, Yolanda María, and Nikola Biller-Andorno. 2021. “Living With Parkinson’s Disease and Connected to the Duodopa Pump: A Qualitative Study”. Qualitative Research in Medicine and Healthcare 4 (3). https://doi.org/10.4081/qrmh.2020.9427.